Providing leadership for the life sciences industry

Placement | Neuro-Bio Ltd appoints Dr. Robert Haigh as Chief Operating Officer

Posted on 08/05/2017

The RSA Group has partnered with Neuro-Bio, a UK-based early stage biopharmaceutical company focusing on neurodegenerative diseases,  to secure the appointment of Dr. Robert Haigh as Chief Operating Officer.

Commenting on the appointment, Mark Howard, Partner at The RSA Group said, “We are delighted that we have been able to assist with this pivotal addition to Neuro-Bio’s leadership team as it continues with its quest to develop novel treatments for Alzheimer’s Disease.”

Read the full release here: http://neuro-bio.com/wp-content/uploads/2017/05/RMH-PR.pdf 

How the RSA group helps global Life Sciences find the best Life Sciences talent

Why choose RSA?

How the RSA group helps global life sciences find the best talent.